Cargando…
Randomised clinical trial: the effectiveness of Gaviscon Advance vs non‐alginate antacid in suppression of acid pocket and post‐prandial reflux in obese individuals after late‐night supper
BACKGROUND: Late‐night supper increases the risk of postprandial reflux from the acid pocket especially in obesity. An alginate‐based, raft‐forming medication may be useful for obese patients with GERD. AIMS: To compare the efficacy of Gaviscon Advance (Reckitt Benckiser, UK) and a non‐alginate anta...
Autores principales: | Deraman, Mohd Adli, Abdul Hafidz, Muhammad Ilham, Lawenko, Rona Marie, Ma, Zheng Feei, Wong, Mung Seong, Coyle, Cathal, Lee, Yeong Yeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318318/ https://www.ncbi.nlm.nih.gov/pubmed/32343001 http://dx.doi.org/10.1111/apt.15746 |
Ejemplares similares
-
Randomised clinical trial: the clinical efficacy and safety of an alginate‐antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in China
por: Sun, J., et al.
Publicado: (2015) -
Gaviscon(® )vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial
por: Pouchain, Denis, et al.
Publicado: (2012) -
Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review
por: Dermyshi, Elda, et al.
Publicado: (2018) -
Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy
por: Strugala, Vicki, et al.
Publicado: (2012) -
Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
por: Jo, Helen E., et al.
Publicado: (2019)